Evidence map›Paper›PMID 36941864›Full record

ArticleAJOG global reports2023

Impacts of embracing 39-week elective induction across an entire labor and delivery unit.

Andrea T Jelks, An Qi Yao, James D Byrne

Open access · goldAbstract read
In one paragraph

Article in AJOG global reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrea T JelksDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center, San Jose, CA (Drs Jelks and Byrne).
An Qi YaoDepartment of Obstetrics and Gynecology, Santa Clara Valley Medical Center, San Jose, CA (Dr Yao).
James D ByrneDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center, San Jose, CA (Drs Jelks and Byrne).
Santa Clara Valley Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInduction of labor among low-risk, 39-week nulliparas increased significantly in the United States following publication of the outcomes of A Randomized Trial of Induction Versus Expectant Management trial. However, the rates of labor induction and outcomes in non-nulliparous patients and the wider impacts on the labor unit have not been reported widely.

objectiveThis study aimed to compare the induction of labor rates and outcomes before and after liberal implementation of 39-week elective induction at a single center. STUDY

designThis was a retrospective cohort study comparing the delivery characteristics of pregnancies 1 year before and 1 year after adoption of a new 39-week elective induction policy at a single, tertiary-care center. Notably, elective induction was not restricted to nulliparas. We examined all live, singleton, in-born deliveries ≥36 weeks gestation, excluding those with fetal anomalies and prolonged antenatal admission. Deliveries at ≥39 weeks gestation were further subcategorized as being high risk (diabetes mellitus, chronic hypertension, intrauterine growth restriction, history of fetal demise or cholestasis) or low risk, nulliparas vs multiparas, and with or without a previous cesarean delivery. Elective deliveries were those without a maternal, fetal, or obstetrical indication. Primary outcomes included gestational age and indications for delivery, rates of labor induction and elective induction, and time from admission to delivery. Secondary outcomes included the rate of cesarean deliveries, indications for cesarean deliveries, and maternal and newborn morbidities. The outcomes were compared using Wilcoxon rank-sum tests or chi-square tests as appropriate. The odds of cesarean delivery were analyzed using multivariate logistic regression and controlling for relevant confounders.

resultsA total of 2672 pre-implementation and 2526 post-implementation deliveries were studied. Among patients at ≥39 weeks gestation, elective delivery increased (pre-implementation, 344/1788 [19.2%] vs post-implementation, 684/1710 [40.0%];

conclusionFollowing adoption of a nonrestrictive, 39-week elective induction policy at a single, tertiary-care center, the rates of 39-week induction of labor and elective inductions increased among nulliparas, multiparas, and those with a previous cesarean delivery. The rate of cesarean delivery was unchanged, and the median time from admission to delivery and the cumulative admission to delivery hours increased significantly. Future studies are needed to further explore the full scope of the impacts on labor unit operations, costs, and patient experiences and outcomes.

Indexed as

39 weeksA Randomized Trial of Induction Versus Expectant Management trialcesareanlow risknullipara

Identifiers

PMID36941864
PMCPMC10024218
OpenAlexW4318426577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.